bladder_001:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: High-grade urothelial carcinoma
  biomarker_profile: "FGFR3 S249C mutation detected. PD-L1 CPS 25. TP53 wild-type."

bladder_002:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Transitional cell carcinoma
  biomarker_profile: "Comprehensive genomic profiling revealed FGFR2 fusion (FGFR2-BICC1), ERBB2 amplification (copy number 12), TP53 R248W mutation, and PD-L1 expression with combined positive score of 45. Tumor mutational burden elevated at 18 mutations per megabase. MSI stable."

bladder_003:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Bladder SCC
  biomarker_profile: "PD-L1 negative. TP53 mutated."

bladder_004:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Papillary urothelial carcinoma
  biomarker_profile: "No actionable alterations identified."

bladder_005:
  morphology: ADENOCARCINOMA
  descriptive_name: Primary vesical adenocarcinoma
  biomarker_profile: "TP53 p.R273H mutation present. TMB intermediate (8 mut/Mb)."

bladder_006:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC
  biomarker_profile: "FGFR3 Y373C."

bladder_007:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Muscle-invasive bladder cancer
  biomarker_profile: "FGFR1 amplification detected by FISH (ratio 3.2). FGFR2 and FGFR3 testing negative. HER2/neu non-amplified. PD-L1 immunohistochemistry shows TPS 80%, CPS 90. TP53 frameshift mutation c.637_638del. TMB-H at 22 mutations/Mb."

bladder_008:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell neuroendocrine carcinoma of bladder
  biomarker_profile: "TP53 R175H mutation identified. Synaptophysin and chromogranin A positive by immunostaining."

bladder_009:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: TCC
  biomarker_profile: "FGFR alteration absent. PD-L1 CPS <1."

bladder_010:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Invasive urothelial carcinoma
  biomarker_profile: "NGS panel: FGFR3-TACC3 fusion positive, ERBB2 S310F mutation, PD-L1 22C3 antibody CPS=15, TP53 wild-type, MSI-stable, TMB 6 mut/Mb."

bladder_011:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Pure squamous differentiation
  biomarker_profile: "Biomarker testing pending."

bladder_012:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: High-grade UC with variant histology
  biomarker_profile: "FGFR2 mutation absent, FGFR3 mutation absent, HER2 2+ equivocal by IHC (FISH pending), PD-L1 expression 5%, TP53 mutant."

bladder_013:
  morphology: ADENOCARCINOMA
  descriptive_name: Urachal adenocarcinoma
  biomarker_profile: "TP53 G245S detected on liquid biopsy. TMB not assessed."

bladder_014:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder cancer
  biomarker_profile: "FGFR3 p.R248C mutation. ERBB2 normal. PDL1 positive (CPS 30). P53 aberrant expression pattern on IHC."

bladder_015:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Non-muscle invasive bladder cancer
  biomarker_profile: "FGFR3 G370C mutation detected by droplet digital PCR."

bladder_016:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: SCNEC
  biomarker_profile: "TP53 splice site mutation."

bladder_017:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Metastatic UC
  biomarker_profile: "Guardant360 cfDNA analysis: FGFR3 S371C (VAF 12%), ERBB2 amplification (plasma copy number 4.2), TP53 Y220C (VAF 8%), PD-L1 not evaluable on liquid biopsy, TMB elevated."

bladder_018:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Transitional cell CA
  biomarker_profile: "All markers negative."

bladder_019:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Squamous cell carcinoma
  biomarker_profile: "PD-L1 IHC: TPS 100%. TP53 deletion exon 5-6. High tumor mutational burden (28 mut/Mb)."

bladder_020:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Papillary UC, high grade
  biomarker_profile: "FGFR testing not performed. PD-L1 CPS 2. TP53 WT."

bladder_021:
  morphology: ADENOCARCINOMA
  descriptive_name: Bladder adenocarcinoma
  biomarker_profile: "Next-generation sequencing revealed TP53 p.R282W mutation and intermediate TMB (7 mutations/Mb)."

bladder_022:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC with squamous differentiation
  biomarker_profile: "FGFR3 K650E, HER2 negative, PD-L1 combined positive score 55, TP53 c.818G>A."

bladder_023:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: MIBC
  biomarker_profile: "No FGFR alterations. ERBB2 not amplified. PD-L1 negative. TP53 mutated. TMB low. MSI stable."

bladder_024:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Low-grade papillary urothelial carcinoma
  biomarker_profile: "FGFR3 mutation positive (specific variant not reported)."

bladder_025:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell bladder cancer
  biomarker_profile: "TP53 loss of function mutation identified."

bladder_026:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Urothelial carcinoma
  biomarker_profile: "FoundationOne CDx: FGFR1 amplification (estimated copy number 8), FGFR3 wild-type, ERBB2 V842I, PD-L1 expression high (TPS 70%), TP53 E285K, TMB 14 mut/Mb, MSI-stable."

bladder_027:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: SqCC of bladder
  biomarker_profile: "PDL1 CPS=10, p53 R273C, TMB analysis failed due to insufficient tissue."

bladder_028:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: TCC, grade 3
  biomarker_profile: "FGFR2/3 negative."

bladder_029:
  morphology: ADENOCARCINOMA
  descriptive_name: Enteric-type adenocarcinoma
  biomarker_profile: "Molecular profiling showed TP53 nonsense mutation p.R213*. TMB assessment: 5 mut/Mb (low)."

bladder_030:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Recurrent UC
  biomarker_profile: "FGFR3-BAIAP2L1 fusion detected by RNA sequencing. ERBB2 normal by IHC and FISH. PD-L1 SP263 assay: IC 2%, TC 15%. TP53 H179R."

bladder_031:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder TCC
  biomarker_profile: "Insufficient tissue for molecular testing."

bladder_032:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: High-grade neuroendocrine carcinoma
  biomarker_profile: "TP53 c.524G>A (p.R175H) mutation."

bladder_033:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Advanced urothelial cancer
  biomarker_profile: "FGFR2 amplification absent, FGFR3 S249C mutation present, HER2 IHC 1+ (negative), programmed death-ligand 1 expression CPS 8, tumor protein p53 mutant, tumor mutational burden intermediate."

bladder_034:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC
  biomarker_profile: "Wild-type for all tested markers."

bladder_035:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Bladder squamous carcinoma
  biomarker_profile: "PD-L1 antibody clone 22C3: CPS 45. TP53 Y234C mutation. TMB-high (19 mutations per megabase)."

bladder_036:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Grade 3 urothelial carcinoma
  biomarker_profile: "FGFR3 p.Y373C detected at 28% allele frequency."

bladder_037:
  morphology: ADENOCARCINOMA
  descriptive_name: Signet ring cell adenocarcinoma
  biomarker_profile: "TP53 immunostaining shows complete loss of expression. TMB: 3 mut/Mb."

bladder_038:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Invasive high-grade papillary UC
  biomarker_profile: "Tempus xT assay: No FGFR1/2/3 alterations detected. ERBB2 copy number normal. PD-L1 positive (CPS=20). TP53 G245V. TMB 11 mut/Mb. Microsatellite stable."

bladder_039:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: NMIBC
  biomarker_profile: "FGFR3 codon 248 mutation."

bladder_040:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell ca
  biomarker_profile: "TP53 mutated (deletion)."

bladder_041:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Transitional cell tumor
  biomarker_profile: "FGFR1 not amplified, FGFR2 wild-type, FGFR3 G380R mutation, HER2/ERBB2 amplification detected (ratio 4.5), PD-L1 28-8 pharmDx assay positive at 35%, p53 mutation present."

bladder_042:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Pure SCC
  biomarker_profile: "No biomarker alterations detected. TMB low."

bladder_043:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Micropapillary variant UC
  biomarker_profile: "ERBB2 amplified by ISH. PD-L1 CPS 60. TP53 R248Q."

bladder_044:
  morphology: ADENOCARCINOMA
  descriptive_name: Bladder ADC
  biomarker_profile: "TP53 c.742C>T."

bladder_045:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Plasmacytoid variant urothelial carcinoma
  biomarker_profile: "CDH1 loss detected. FGFR3 negative. PD-L1 TPS <1%. TP53 mutant."

bladder_046:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC, high grade
  biomarker_profile: "FGFR3 mutation not detected by PCR."

bladder_047:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Bladder SCNC
  biomarker_profile: "TP53 R280T identified on tumor sequencing."

bladder_048:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Metastatic bladder cancer
  biomarker_profile: "Liquid biopsy results: FGFR3 S371C (allele fraction 4.2%), ERBB2 copy number gain, TP53 H193R (allele fraction 8.1%), TMB not evaluable in plasma."

bladder_049:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Urothelial neoplasm
  biomarker_profile: "All molecular markers within normal limits."

bladder_050:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Moderately differentiated squamous carcinoma
  biomarker_profile: "PD-L1 expression: tumor proportion score 90%. TP53 exon 8 mutation. TMB 15 mut/Mb."

bladder_051:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: pT2 urothelial carcinoma
  biomarker_profile: "FGFR3 K650M mutation, ERBB2 non-amplified, PD-L1 5%, TP53 wild-type, TMB 4 mut/Mb, MSI-S."

bladder_052:
  morphology: ADENOCARCINOMA
  descriptive_name: Mucinous adenocarcinoma of bladder
  biomarker_profile: "TP53 immunohistochemistry: mutant pattern (>90% strong nuclear staining)."

bladder_053:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Carcinoma in situ
  biomarker_profile: "FGFR3 testing deferred."

bladder_054:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: High-grade TCC with glandular differentiation
  biomarker_profile: "Comprehensive panel: FGFR2 fusion negative, FGFR3 R248C present, HER2 2+ (FISH non-amplified), PD-L1 IC+TC=12%, TP53 Y220C, TMB intermediate (9 mut/Mb)."

bladder_055:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Mixed small cell/urothelial carcinoma
  biomarker_profile: "TP53 c.722C>T (p.S241F). Neuroendocrine markers positive."

bladder_056:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder UC
  biomarker_profile: "FGFR3 Y375C."

bladder_057:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Keratinizing SCC
  biomarker_profile: "PD-L1 scoring: CPS=3. TP53 mutated. TMB testing unsuccessful."

bladder_058:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Papillary transitional cell carcinoma
  biomarker_profile: "FGFR1 copy number normal, FGFR3 mutation absent, ERBB2/neu not amplified, PD-L1 <1%, TP53 mutation not detected."

bladder_059:
  morphology: ADENOCARCINOMA
  descriptive_name: Clear cell adenocarcinoma
  biomarker_profile: "Targeted NGS panel: TP53 p.R249S detected. TMB low (2 mut/Mb)."

bladder_060:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Locally advanced UC
  biomarker_profile: "FGFR3-INA fusion identified. HER2 negative (0). PD-L1 antibody SP142: IC2. TP53 frameshift mutation. TMB 13/Mb."

bladder_061:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder carcinoma
  biomarker_profile: "Pan-negative molecular profile."

bladder_062:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: EP carcinoma
  biomarker_profile: "TP53 homozygous deletion."

bladder_063:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: High-risk NMIBC
  biomarker_profile: "FGFR3 S249C mutation detected by allele-specific PCR. PD-L1 and other markers not tested."

bladder_064:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC with nested variant
  biomarker_profile: "Molecular alterations: FGFR2 not altered, FGFR3 K650E, ERBB2 L755S, PD-L1 positive (CPS 40), TP53 R273H, TMB-high, MSI-stable."

bladder_065:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Invasive squamous cell carcinoma
  biomarker_profile: "PDL1 immunohistochemistry CPS 18, p53 G266E, elevated mutational burden."

bladder_066:
  morphology: ADENOCARCINOMA
  descriptive_name: Bladder adenoca
  biomarker_profile: "TP53 analysis: wild-type. TMB: 6 mut/Mb."

bladder_067:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Recurrent high-grade UC
  biomarker_profile: "ctDNA analysis reveals FGFR3 Y373C at 2.3% MAF, TP53 R175H at 5.1% MAF."

bladder_068:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Transitional epithelial carcinoma
  biomarker_profile: "FGFR1/2/3 pan-negative. HER2 IHC negative (1+). PD-L1 negative. TP53 negative. Low TMB."

bladder_069:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Bladder neuroendocrine tumor
  biomarker_profile: "TP53 p.V157F mutation. CD56 positive, synaptophysin positive."

bladder_070:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Stage IV UC
  biomarker_profile: "OncoPrint results: FGFR3 fusion with TACC3, ERBB2 amplification (CN=8), PD-L1 expression 25% CPS, TP53 splice acceptor variant, hypermutated (TMB 24 mut/Mb)."

bladder_071:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: TCC of bladder
  biomarker_profile: "No variants of clinical significance identified."

bladder_072:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Non-keratinizing SCC
  biomarker_profile: "PD-L1 TPS: 55%. TP53 c.818G>A (p.R273H). TMB intermediate."

bladder_073:
  morphology: ADENOCARCINOMA
  descriptive_name: Colloid adenocarcinoma
  biomarker_profile: "TP53 mutation p.P278S."

bladder_074:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Sarcomatoid UC
  biomarker_profile: "FGFR testing negative across all subtypes. ERBB2 normal. PD-L1 highly positive (CPS 85). TP53 double mutation (R248W and Y163C). TMB very high (32 mut/Mb)."

bladder_075:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Low-grade UC
  biomarker_profile: "FGFR3 G370C identified."

bladder_076:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Small cell
  biomarker_profile: "TP53 c.455C>T."

bladder_077:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Invasive UC with micropapillary features
  biomarker_profile: "HER2 amplified (ratio 6.2 by FISH). FGFR3 WT. PD-L1 combined positive score: 15. TP53 mutant by IHC."

bladder_078:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Papillary urothelial neoplasm
  biomarker_profile: "Molecular markers not indicated."

bladder_079:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Basaloid SCC
  biomarker_profile: "Checkpoint inhibitor biomarkers: PD-L1 CPS 72, TMB-H (21 mut/Mb). TP53 Y205C."

bladder_080:
  morphology: ADENOCARCINOMA
  descriptive_name: Primary bladder adenocarcinoma
  biomarker_profile: "Next-gen sequencing: TP53 R282W mutation detected. Mutational burden: 4 mut/Mb (low)."

bladder_081:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Metastatic TCC
  biomarker_profile: "Circulating tumor DNA: FGFR3 S249C (VAF 6.8%), ERBB2 V777L (VAF 2.1%), TP53 R280K (VAF 11%), estimated TMB moderate."

bladder_082:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC NOS
  biomarker_profile: "FGFR3 negative by sequencing."

bladder_083:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Oat cell carcinoma
  biomarker_profile: "TP53 inactivating mutation present. TTF-1 negative, neuroendocrine markers positive."

bladder_084:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: pTa low-grade papillary UC
  biomarker_profile: "FGFR3 mutation analysis positive (Y375C). No additional testing performed."

bladder_085:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Transitional cell carcinoma with squamous metaplasia
  biomarker_profile: "Biomarker panel: FGFR1 not amplified, FGFR3 R248C mutation, HER2/neu equivocal (2+), PD-L1 22C3: CPS=28, p53 overexpression by IHC, TMB 8 mutations/Mb, MSI stable."

bladder_086:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Well-differentiated squamous CA
  biomarker_profile: "PD-L1 expression low (CPS 2). TP53 wild-type. TMB analysis pending."

bladder_087:
  morphology: ADENOCARCINOMA
  descriptive_name: Glandular carcinoma of bladder
  biomarker_profile: "Genomic testing shows TP53 c.659A>G mutation."

bladder_088:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: High-grade infiltrating UC
  biomarker_profile: "FGFR2-CASP7 fusion detected. ERBB2 non-amplified. PD-L1 score: TPS 40%, CPS 48%. TP53 H179Y. TMB elevated (16 mut/Mb)."

bladder_089:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Urothelial ca
  biomarker_profile: "Testing incomplete due to tissue exhaustion."

bladder_090:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: High-grade NE carcinoma
  biomarker_profile: "TP53 gene deletion identified by FISH."

bladder_091:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Advanced bladder cancer
  biomarker_profile: "Gene expression profiling: FGFR3-activating mutation absent, ERBB2 expression normal, immune checkpoint marker PD-L1 positive (15%), TP53 mutation detected, intermediate mutational load."

bladder_092:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder urothelial carcinoma
  biomarker_profile: "FGFR3 K652E mutation."

bladder_093:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Invasive keratinizing SCC
  biomarker_profile: "Immunotherapy biomarkers: PD-L1 CPS=33, TMB-high (18 mut/Mb). TP53 p.C238Y."

bladder_094:
  morphology: ADENOCARCINOMA
  descriptive_name: Vesical adenocarcinoma
  biomarker_profile: "Molecular findings: TP53 gene mutation (R175H). Low tumor mutational burden."

bladder_095:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: UC with lymphoepithelioma-like features
  biomarker_profile: "PD-L1 extremely high (CPS 95). FGFR3 wild-type. TP53 mutated. TMB moderate (10 mut/Mb)."

bladder_096:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Grade 2 TCC
  biomarker_profile: "FGFR3 molecular testing negative."

bladder_097:
  morphology: SMALL_CELL_CARCINOMA
  descriptive_name: Combined small cell and UC
  biomarker_profile: "TP53 p.R248W detected in both components."

bladder_098:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Metastatic urothelial carcinoma
  biomarker_profile: "MSK-IMPACT: FGFR3 S371C mutation, ERBB2 copy neutral, PD-L1 28-8 assay positive (TPS 20%, CPS 35%), TP53 G266V, TMB 12 mut/Mb, microsatellite stable, HRD score low."

bladder_099:
  morphology: UROTHELIAL_CARCINOMA
  descriptive_name: Bladder transitional cell CA
  biomarker_profile: "All evaluated biomarkers negative including FGFR1-3, ERBB2, and PD-L1."

bladder_100:
  morphology: SQUAMOUS_CELL_CARCINOMA
  descriptive_name: Poorly differentiated SCC of bladder
  biomarker_profile: "PD-L1 antibody clone SP263 shows combined positive score of 67. TP53 truncating mutation (p.R213*). Hypermutated phenotype with TMB of 25 mutations per megabase."